Why nicotine deaddiction?
- Prevalence of tobacco use among adults is 26.8% in India (Global Adult Tobacco Survey (GATS) 2016-17)
- It is one of the major causes of morbidity and mortality
- Current interventions like pharmacotherapy and behavioural interventions have limitations
- Nicotine Replacement Therapy (NRT) as well as non-NRT have their own side effects
- Poor adherence by the patient to treatment
- One of the major thrust areas for National Tobacco Control Programme (NTCP) is to set-up and strengthen tobacco cessation facilities.
Who can opt for DTMS for smoking cessation?
Ø Any patient who has been primarily under the treatment for other medical illnesses for which smoking is a risk factor or it delays the treatment outcomes
Ø A person who desires to quit smoking or control the cravings
DTMS treatment for smoking:
BrainsWay’s H4 coil (US-FDA approved) is used to stimulate bilateral insula and prefrontal cortex to help the person to reduce/quit smoking.